Genscript Biotech Stock (GNNSF)

Track Genscript Biotech stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.

$4.25

▲ +2.10 (+97.67%) past year

Closed · Updated Oct 23, 10:47 AM ET

Market Cap

$9.16B

P/E Ratio

—

1Y Return

+97.67%

EPS (TTM)

-$0.29

Read the latest TheStreet Pro articles mentioning Genscript Biotech, including market roundups, portfolio updates, trade ideas, and investing analysis.

Articles

1 article

trade-ideas Biotech Stocks Are Surging in 2026. This One Stands Out After a Pullback.
Bret JensenJul 5, 2026
GNNSF JNJ LEGN

Daily Diary Mentions

0 mentions

No diary mentions for GNNSF yet.